Source: Brazilian Journal of Cardiovascular Surgery. Unidade: FMRP
Subjects: CIRCULAÇÃO EXTRACORPÓREA, AZUL DE METILENO, CHOQUE, FARMACOTERAPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
EVORA, Paulo Roberto Barbosa e GOMES, Walter J. Why methylene blue is the only option for blocking the cGMP/NO pathway in the treatment of vasoplegic shock? [Editorial]: "reasons that reason itself does not know…". Brazilian Journal of Cardiovascular Surgery. São Paulo: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.21470/1678-9741-2021-0957. Acesso em: 18 nov. 2024. , 2021APA
Evora, P. R. B., & Gomes, W. J. (2021). Why methylene blue is the only option for blocking the cGMP/NO pathway in the treatment of vasoplegic shock? [Editorial]: "reasons that reason itself does not know…". Brazilian Journal of Cardiovascular Surgery. São Paulo: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.21470/1678-9741-2021-0957NLM
Evora PRB, Gomes WJ. Why methylene blue is the only option for blocking the cGMP/NO pathway in the treatment of vasoplegic shock? [Editorial]: "reasons that reason itself does not know…" [Internet]. Brazilian Journal of Cardiovascular Surgery. 2021 ; 36( 3): I-II.[citado 2024 nov. 18 ] Available from: https://doi.org/10.21470/1678-9741-2021-0957Vancouver
Evora PRB, Gomes WJ. Why methylene blue is the only option for blocking the cGMP/NO pathway in the treatment of vasoplegic shock? [Editorial]: "reasons that reason itself does not know…" [Internet]. Brazilian Journal of Cardiovascular Surgery. 2021 ; 36( 3): I-II.[citado 2024 nov. 18 ] Available from: https://doi.org/10.21470/1678-9741-2021-0957
